PRLR and metabolic dysfunction-associated steatotic liver disease: Zhang P et al. [24], in a study of 456 patients with NAFLD and 403 patients without diagnosed NAFLD, showed that serum prolactin (PRL) and hepatic prolactin receptor (PRLR) expression were significantly reduced in patients with NAFLD and negatively correlated with CD36 expression.